86 related articles for article (PubMed ID: 17006721)
1. Oral contraceptive use and risk of breast carcinoma in situ (United States).
Gill JK; Press MF; Patel AV; Bernstein L
Cancer Causes Control; 2006 Nov; 17(9):1155-62. PubMed ID: 17006721
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives and breast cancer risk among younger women.
Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive use and risk of breast carcinoma in situ.
Nichols HB; Trentham-Dietz A; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2262-8. PubMed ID: 18006914
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives and the risk of ductal breast carcinoma in situ.
Claus EB; Stowe M; Carter D
Breast Cancer Res Treat; 2003 Sep; 81(2):129-36. PubMed ID: 14572155
[TBL] [Abstract][Full Text] [Related]
5. Risk of breast cancer associated with short-term use of oral contraceptives.
Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R
Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547
[TBL] [Abstract][Full Text] [Related]
6. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for in situ breast cancer.
Longnecker MP; Bernstein L; Paganini-Hill A; Enger SM; Ross RK
Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):961-5. PubMed ID: 8959317
[TBL] [Abstract][Full Text] [Related]
8. Impact of reproductive factors and lactation on breast carcinoma in situ risk.
Meeske K; Press M; Patel A; Bernstein L
Int J Cancer; 2004 May; 110(1):102-9. PubMed ID: 15054874
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Haile RW; Thomas DC; McGuire V; Felberg A; John EM; Milne RL; Hopper JL; Jenkins MA; Levine AJ; Daly MM; Buys SS; Senie RT; Andrulis IL; Knight JA; Godwin AK; Southey M; McCredie MR; Giles GG; Andrews L; Tucker K; Miron A; Apicella C; Tesoriero A; Bane A; Pike MC; ; ; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1863-70. PubMed ID: 17021353
[TBL] [Abstract][Full Text] [Related]
10. Do oral contraceptive agents affect the risk of breast cancer? A meta-analysis of the case-control reports.
Hawley W; Nuovo J; DeNeef CP; Carter P
J Am Board Fam Pract; 1993; 6(2):123-35. PubMed ID: 8452064
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk and oral contraceptive use: results from a large case-control study.
Weinstein AL; Mahoney MC; Nasca PC; Leske MC; Varma AO
Epidemiology; 1991 Sep; 2(5):353-8. PubMed ID: 1742384
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking and risk of breast carcinoma in situ.
Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252
[TBL] [Abstract][Full Text] [Related]
13. Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
Kotsopoulos J; Lubinski J; Moller P; Lynch HT; Singer CF; Eng C; Neuhausen SL; Karlan B; Kim-Sing C; Huzarski T; Gronwald J; McCuaig J; Senter L; Tung N; Ghadirian P; Eisen A; Gilchrist D; Blum JL; Zakalik D; Pal T; Sun P; Narod SA;
Breast Cancer Res Treat; 2014 Feb; 143(3):579-86. PubMed ID: 24458845
[TBL] [Abstract][Full Text] [Related]
14. The association between oral contraceptive use and lobular and ductal breast cancer in young women.
Nyante SJ; Gammon MD; Malone KE; Daling JR; Brinton LA
Int J Cancer; 2008 Feb; 122(4):936-41. PubMed ID: 17957781
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
16. Lifetime recreational exercise activity and risk of breast carcinoma in situ.
Patel AV; Press MF; Meeske K; Calle EE; Bernstein L
Cancer; 2003 Nov; 98(10):2161-9. PubMed ID: 14601085
[TBL] [Abstract][Full Text] [Related]
17. Oral contraceptive use and risk of breast cancer in middle-aged women.
Rossing MA; Stanford JL; Weiss NS; Habel LA
Am J Epidemiol; 1996 Jul; 144(2):161-4. PubMed ID: 8678047
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.
Modugno F; Ness RB; Allen GO; Schildkraut JM; Davis FG; Goodman MT
Am J Obstet Gynecol; 2004 Sep; 191(3):733-40. PubMed ID: 15467532
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives, postmenopausal hormones, and risk of asynchronous bilateral breast cancer: the WECARE Study Group.
Figueiredo JC; Bernstein L; Capanu M; Malone KE; Lynch CF; Anton-Culver H; Stovall M; Bertelsen L; Haile RW; Bernstein JL;
J Clin Oncol; 2008 Mar; 26(9):1411-8. PubMed ID: 18250348
[TBL] [Abstract][Full Text] [Related]
20. Do thyroid disorders increase the risk of breast cancer?
Simon MS; Tang MT; Bernstein L; Norman SA; Weiss L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone K; Marchbanks PA; McDonald JA; Strom BL; Wilson HG; Spirtas R
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1574-8. PubMed ID: 12496046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
